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1. Introduction 
Cell populations consisting predominantly of 
macrophages emit chemiluminescence when they are 
phagocytosing zymosan particles [ 1,2] or bacteria 
[ 1,3,4] . This chemiluminescence is considered indic- 
ative of the generation of reactive species of oxygen 
(Os-, HzOz, OH’), which are formed as intermediates 
during the stepwise reduction of molec,ular oxygen by 
one-electron donors, and of singlet O2 (A02) generated 
during the disproportionation of Os-. These species 
emit light in the presence of polyunsaturated fatty 
acids, polysaccharides or easily oxidizable substances 
like luminol [5]. As these species of oxygen are con- 
sidered important in the killing mechanism of phago- 
cytic cells [6] chemiluminescence may be viewed as a 
manifestation of their microbicidal activity [7] . Inde- 
pendently it has been reported that macrophages 
form and release prostaglandins (PCs) [8] under con- 
ditions comparable to those that evoke chemilumi- 
nescence. PGs have been implicated as mediators in 
inflammation and cellular immunity [9-l l] . 
We have studied chemiluminescence, PG formation 
and their possible interrelationship in macrophages 
cultivated from bone marrow precursor cells of mice. 
By morphological criteria these cells are not con- 
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taminated by granulocytes or lymphocytes and appear 
as a pure population of macrophages [121. 
During phagocytosis of zymosan these cells 
produce chemiluminescence and immunoreactive 
PGs mainly of the E-type, but also measurable 
amounts of PGF20. In addition, we have found sig- 
nificant amounts of thromboxane B*(TXB?). Chemi- 
luminescence, PG and TX synthesis can also be 
elicited in the absence of phagocytosis by the bivalent 
metal ion ionophore A23187. Most important, 
however, the chemiluminescence in either case can be 
inhibited by PGs of the E-type. The latter findings 
suggest hat PGs released by macrophages may, 
apart from other immune cells [9-l 1,13-161, also 
control the activity of the macrophage itself. 
2. Materials and methods 
Zymosan, lot no. 6757, was obtained from ICN 
Pharmaceuticals, Cleveland, OH. The bivalent metal 
ion ionophore A23 187 [ 171 was kindly provided by 
Dr R. L. Hamill (Eli Lilly). All PGs and TXBz were 
gifts from Dr J. Pike (Upjohn Co., Kalamazoo). 
Macrophages were cultivated from bone marrow 
cells obtained from C57/Bl mice and were harvested 
on days 6-8 [ 121. Chemiluminescence was measured 
at 37°C in a liquid scintillation spectrometer (Packard 
Tri-carb model 3002) set in the off-coincidence mode. 
PCs and TXBz were estimated by radioimmunoassay 
asin [18]. 
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3. Results 
Addition of zymosan particles to a suspension of 
macrophages (lo6 tells/5.0 ml) led, after a delay of 
10 min, to a significant increase in chemiluminescence 
that reached peak intensity in 50-70 min and there- 
after declined (fig.1 a). This response could be detected 
in the absence of luminol. Its intensity was not 
significantly altered if the cells were allowed to 
adhere to the walls of the glass vials. The adherent 
cells responded more quickly to zymosan, however, 
and the maximum chemiluminescence occurred only 
20-30 min after its addition (results not shown). In 
each case mainly immunoreac tive PGEa, but also 
smaller amounts of F, as well as TXBz accumulated 
in the incubation medium during the period of 
a 
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Fig.1. Time courses of chemiluminescence (a) and prosta- 
glandin and thromboxane synthesis (b) in bonemarrow- 
derived cultured mouse macrophages after addition of 
zymosan. Freshly harvested macrophages (106) were sus- 
pended in 5 .O ml Eagle’s medium buffered with 20 mM 
Hepes, pH 7.4 ; after temperature quilibration, the chemi- 
luminescence was measured at 37°C in a Packard Tri-carb 
spectrometer. Zymosan (2.5 mg) was added and the light 
emission measured for 0.2 min intervals (in duplicate) every 
10 min for 2 h (tig.la (o-o)). At the end of the incubation 
period shown (tlg.lb), the vials were cooled on ice, the cells 
sedimented (400 X g, 10 min) and PCs F,, (o-o) and E, 
(a-a) as well as TXB, (0-b) present in the incubation medium 
were determined, without prior extraction. In each case, 
control incubations were carried out without the addition of 
zymosan (closed symbols in fig.la,b). All values are corrected 
for the concentrations of PCs and TXB, present in the 
incubation medium. The results are expressed as means * SEM 
of 4 (in tIg.la) and 6 (in fig.lb) experiments, respectively. 
time Irno-8) 
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Fig.2. Effect of the ionophore A23187 on chemiluminescence 
(a) and prostaglandin and thromboxane synthesis (b) in bone- 
marrow-derived cultured mouse macrophages (106). Chemi- 
luminescence was measured at 12 s intervals after the addition 
of 0.1 ml luminol-saturated foetal calf serum [ 31 : to cells 
only (o-o); to cells after addition of the optimum concentra- 
tion, judged by peak chemiluminescence, of ionophore 
A23187 (0.5 PM) (o-o); to cells after 0.5 PM A23187 follow- 
ing a 1.0 min preincubation with 2.8 PM prostaglandin E, 
(n-a). Prostaglandins and thromboxane B, were measured 
in the Incubation medium from which the cells had been 
removed by centrifugation (400 X g, 10 min) 15 mm after 
the addition of 0.5 PM A23187.5 ~1 dimethylsulphoxide or 
5 ~170% ethanol, the solvents used for A23187 and PGE, , 
respectively, had no effect on chemiluminescence or
prostaglandin synthesis. Other experimental conditions were 
as in tig.1, except that incubation medium was total vol. 
2.5 ml. The results of a typical experiment are given in 
fig.2a; in fig.2b, the results are expressed as means f SEM of 
A23187-stimulated cells from which control values (i.e., from 
cells incubated in solvent alone) have been subtracted. 
stimulated chemiluminescence (fig.1 b). The synthesis 
of PGs and TXBa was completely blocked by 28 I.~M 
indomethacin, which failed, however, to affect 
chemihuninescence under the experimental conditions 
used (table 1). 
A similar, but greatly accelerated, chemilumines- 
cence response was obtained in the absence of phago- 
cytosis when macrophages were incubated with the 
ionophore A23 187 at a predetermined optimal con- 
centration (fig.2a). This response of less than 4 min 
duration, could be demonstrated only in the presence 
of luminol(5amino-2,3-dihydro-I ,4 phtalazinedione) 
137 
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Table 1 
Effect of added prostaglandins and indomethacin on zymosan-dependent 
chemiluminescence in bone-marrowderived mouse macrophagesa 
Peak chemiluminescence as % control 
Treatment PM x SE n P 
Control 100 - 6 - 
Indomethacin in 28 100.4 8.1 6 n.s. 
PGE, 0.28 71.5 5.9 6 <O.Ol 
PGE, 2.80 61.2 5.4 6 <0.005 
PGE* 0.28 76.3 6.3 5 <0.025 
PGE, 2.80 71.0 5.8 5 <0.02 
PGF,, 0.28 98.9 6.3 5 n.s. 
PGF,o 2.80 96.6 7.0 5 n.s. 
PGFXY 0.28 90.0 5.8 5 n.s. 
PGF, 2.80 92.3 7.4 5 n.s. 
a Experiments performed as in fig.1. The peak chemiluminescence of 6 control experi- 
ments was 16 643 f 1667 cpm (mean + SEM). Student’s f-tests for paired observations 
were performed on the raw data with o>O.O5 considered non-significant (n.s.). Prosta- 
glandins were added in 5 ri 70% ethanol, which had no effect on chemiluminescence 
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[S] . This compound replaces in these experiments 
zymosan as an indicator for the presence of one or 
several of the reactive oxygen species mentioned 
above. A23 187 also induced the synthesis of large 
amounts of PGEz as well as some Full and TXBZ 
(fig2b). Their formation was inhibited by indo- 
methacin at low concentrations (0.1-l .O PM) that 
had no significant effect on the accompanying chemi- 
luminescence (results not shown). 
PCs of the E-type, but not PGFto and PGFza 
significantly suppressed the chemihtminescence 
associated with zymosan addition (table l), and 
addition of PGEr blocked the chemiluminescence 
induced by A23 187 (fig.2a). Furthermore, a reversible 
inhibition of particle uptake, associated with striking 
changes in cell morphology, has also been observed 
in PGEr-treated macrophages (R. L. Oropeza-Rendon, 
V. Speth and H. F., unpublished observations). The 
possibility that these inhibitory effects might extend 
to PG synthesis itself was not tested in the present 
work because of the interference of the added con- 
centrations of PGEr with the radioimmunoassays of 
PGEz , PGF20 and TXB?. 
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4. Discussion 
The present finding that PG synthesis is inhibited 
by indomethacin, while chemiluminescence is not, 
indicates that these two processes are not firmly 
coupled in macrophages. The failure, on the other 
hand, to see chemiluminescence nhanced in the 
presence of indomethacin indicates that under our 
experimental conditions the endogenously produced 
concentrations of PGE are too low to affect chemi- 
luminescence. The fact, however, that PG synthesis 
and chemiluminescence can be evoked by common 
stimuli suggests that these two processes may have 
at least one early step in common. This step, as 
suggested by the ionophore-induced stimulation of 
both processes, may relate to either an increase in the 
steady-state level of cytoplasmic Ca” or to the 
specific activation of a Ca2”-requiring enzyme. The 
activation of a Ca’trequiring phospholipase A [ 191, 
for example, which is known to be the rate-limiting 
reaction for PG synthesis [20,21] in a number of 
tissues, is an obligatory step under conditions where 
the precursor fatty acids are derived from endogenous 
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phospholipids [22] . The calcium ionophore A23187 
has indeed been shown to activate phospholipase Aa 
in platelets [23], and there is evidence that this also 
occurs in several other tissues, including lymphoma 
cells and polymorphonuclear leucocytes [24]. How- 
ever, it is not clear at present, whether, or how, phos- 
pholipase activation is involved in the initiation of 
chemihrminescence. 
Prostaglandins have been suggested as mediators 
between immune ceils [9-l 1,13-161, and E-type 
PGs have been shown to inhibit several ymphocyte 
functions, like production of lymphokines [lo] , 
cytolytic activity [25], or the response to mitogens 
[ 13 ,161. The results presented here indicate that the 
PGs released by macrophages may also have a modu- 
lating effect on these cells themselves. Phagocytosis is 
inhibited by the E-type PGs, and the observed sup- 
pression in chemiluminescence may be taken as 
indication of an inhibition of the microbicidal activity 
of these cells [7] . The possible pathophysiological 
significance of these processes is emphasized by the 
fact that macrophages produce mainly PGs of the 
E-type, and only the E-types exert such effects. 
Furthermore, the PG concentrations used in these 
experiments (280 nM) are of the same order of 
magnitude as those found in some inflammatory 
conditions in vivo, e.g., in synovial fluids of patients 
with rheumatoid arthritis [26] or in epidermis of 
psoriasis [27]. 
An interesting feedback mechanism for the 
regulation of cellular immune response was proposed 
[lo] and it was found that macrophage-born PGs of 
the E-type inhibit lymphokine secretion of lympho- 
cytes. Our findings that PGs of macrophages could 
exert some kind of feedback control on the activities 
of these cells themselves adds a new aspect to 
macrophage-lymphocyte interaction in inflammatory 
and immune reactions. 
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